View in EDS HTML Full Text PDF Full Text

Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide.

Saved in:
Bibliographic Details
Title: Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricide.
Authors: Dobson, Lachlan J1 (AUTHOR), Hock, Barry D2,3 (AUTHOR), Drabble, Ariana HT1 (AUTHOR), Goddard, Liping2,3 (AUTHOR), McKenzie, Judith L2,3 (AUTHOR), MacPherson, Sean A2,3 (AUTHOR), McLellan, Alexander D1,4 (AUTHOR) alex.mclellan@otago.ac.nz
Source: Clinical & Translational Immunology. May2026, Vol. 15 Issue 5, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20500068
DOI:10.1002/cti2.70098